Financhill
Back

Embecta 10K Form

Buy
51

EMBC
Embecta

Last Price:
13.62
Seasonality Move:
-7.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EMBC News And Ratings

See the #1 stock for the next 7 days that we like better than EMBC

EMBC Financial Statistics

Sales & Book Value

Annual Sales: $1.12B
Cash Flow: $-11.8M
Price / Cash Flow: 60.83
Annual Sales: $-13.24
Price / Book: 0

Profitability

EPS (TTM): 1.20000
Net Income (TTM): $69.7M
Gross Margin: $749.9M
Return on Equity: 0%
Return on Assets: 5.67%

Embecta Earnings Forecast

Key Embecta Financial Ratios

  • The Gross Profit Margin over the past 5 years for EMBC is 66.91%.
  • The Selling, General & Administrative Expenses for EMBC have been equal to 30.45% of Gross Profit Margin.
  • The Research & Development expenses have been 7.60% of Revenue.
  • The Interest Expense is 151.99% of Operating Income.
  • The Net Earning history of EMBC is 6.28% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 0 years.

Embecta Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: EMBC
Website: embecta.com

Debt

Debt-to-Equity Ratio: -2.1
Current Ratio: 2.11
Quick Ratio: 1.4

Price-to-Earnings

Trailing P/E Ratio: 11.82
Forward P/E Ratio: 6.22

EMBC Technical Analysis vs Fundamental Analysis

Buy
51
Embecta (EMBC) is a Buy

Is Embecta a Buy or a Sell?

  • Embecta stock is rated a Buy
    The current Embecta [EMBC] share price is $13.61. The Score for EMBC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.